Pawel Robak (Paweł Robak)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 23

Top Topics

Multiple Myeloma

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Capillary Electrophoresis

Top Venues

Expert opinion on drug metabolism & toxicology

Leukemia & lymphoma

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Wolska-Washer, Pawel Robak, Magdalena Witkowska, Tadeusz Robak
Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma. Expert opinion on drug metabolism & toxicology (2024)
Anna Wolska-Washer, Pawel Robak, Magdalena Witkowska, Tadeusz Robak
Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma. Expert opinion on drug metabolism & toxicology (2024)
Anna Wolska-Washer, Pawel Robak, Magdalena Witkowska, Tadeusz Robak
Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma. Expert opinion on drug metabolism & toxicology 20 (4) (2024)
Tadeusz Kubicki, Dominik Dytfeld, David Barnidge, Dhananjay Sakrikar, Anna Przybyłowicz-Chalecka, Krzysztof Jamroziak, Pawel Robak, Jarosław Czyż, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wróbel, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Puła, Lukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Ken Jiang, Jennifer H Cooperrider, Andrzej J Jakubowiak, Benjamin A Derman
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma. Blood 144 (9) (2024)
Tadeusz Kubicki, Dominik Dytfeld, David Barnidge, Dhananjay Sakrikar, Anna Przybyłowicz-Chalecka, Krzysztof Jamroziak, Pawel Robak, Jarosław Czyż, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wróbel, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Puła, Lukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Ken Jiang, Jennifer H Cooperrider, Andrzej J Jakubowiak, Benjamin A Derman
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma. Blood 144 (9) (2024)
Tadeusz Robak, Marcin Braun, Anna Guminska, Elżbieta Iskierka-Jażdżewska, Pawel Robak
Successful treatment with cladribine in a patient with Rosai-Dorfman disease complicated by severe, prolonged marrow aplasia. Leukemia & lymphoma (2024)
Tadeusz Kubicki, Dominik Dytfeld, David R Barnidge, Dhananjay Sakrikar, Anna Przybyłowicz-Chalecka, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Agata Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wróbel, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak, Lidia Anna Gil, Bartosz Puła, Lukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Ken Jiang, Jennifer Helen Cooperrider, Andrzej J Jakubowiak, Benjamin A Derman
Mass Spectrometry-Based Assessment of M-protein in Peripheral Blood During Maintenance Therapy in Multiple Myeloma. Blood (2024)
Anna Wolska-Washer, Pawel Robak, Magdalena Witkowska, Tadeusz Robak
Metabolic and toxicological considerations of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma. Expert opinion on drug metabolism & toxicology 20 (4) (2024)
Tadeusz Robak, Marcin Braun, Anna Guminska, Elżbieta Iskierka-Jażdżewska, Pawel Robak
Successful treatment with cladribine in a patient with Rosai-Dorfman disease complicated by severe, prolonged marrow aplasia. Leukemia & lymphoma 65 (8) (2024)
Anna Puła, Pawel Robak, Dariusz Jarych, Damian Mikulski, Małgorzata Misiewicz, Izabela Dróżdż, Wojciech Fendler, Janusz Zbigniew Szemraj, Tadeusz Robak
The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. International journal of molecular sciences 24 (3) (2023)
Pawel Robak, Magda Witkowska, Anna Wolska-Washer, Tadeusz Robak
The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies. Expert opinion on drug discovery (2023)
Tadeusz Robak, Anna Krawczyńska, Barbara Cebula-Obrzut, Marta Urbaniak, Elżbieta Iskierka-Jażdżewska, Pawel Robak
Atypical Chronic Lymphocytic Leukemia-The Current Status. Cancers 15 (18) (2023)
Anna Puła, Pawel Robak, Dariusz Jarych, Damian Mikulski, Małgorzata Misiewicz, Izabela Dróżdż, Wojciech Fendler, Janusz Zbigniew Szemraj, Tadeusz Robak
The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. International journal of molecular sciences 24 (3) (2023)
Anna Puła, Tadeusz Robak, Izabela Dróżdż, Konrad Stawiski, Aleksander Rycerz, Małgorzata Misiewicz, Pawel Robak
Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study. Leukemia & lymphoma (2023)
Anna Puła, Pawel Robak, Dariusz Jarych, Damian Mikulski, Małgorzata Misiewicz, Izabela Dróżdż, Wojciech Fendler, Janusz Zbigniew Szemraj, Tadeusz Robak
The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens. International journal of molecular sciences 24 (3) (2023)
Tadeusz Robak, Pawel Robak
Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials. Expert opinion on investigational drugs (2023)
Magdalena Witkowska, Agata Majchrzak, Pawel Robak, Anna Wolska-Washer, Tadeusz Robak
Metabolic and toxicological considerations for phosphoinositide 3-kinase delta inhibitors in the treatment of chronic lymphocytic leukemia. Expert opinion on drug metabolism & toxicology (2023)
Tadeusz Robak, Jaroslaw D Kasprzak, Dorota Jesionek-Kupnicka, Michał Soin, Pawel Robak
Small lymphocytic lymphoma in the heart twenty years after lymphoma diagnosis. Leukemia & lymphoma 64 (4) (2023)
Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wrobel, Krzysztof Jamroziak, Pawel Robak, Jarosław Czyż, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Puła, Justyna Rybka, Maciej Majcherek, Lidia Usnarska-Zubkiewicz, Lukasz Szukalski, Jan Maciej Zaucha, Damian Mikulski, Olga Czabak, Oscar B Lahoud, Andrew T Stefka, Benjamin A Derman, Andrzej J Jakubowiak
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial. British journal of haematology (2023)
Damian Mikulski, Pawel Robak, Wiktoria Ryżewska, Kamila Stańczak, Kacper Kościelny, Joanna Góra-Tybor, Tadeusz Robak
Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study. Journal of clinical medicine 11 (19) (2022)
Tadeusz Robak, Jaroslaw D Kasprzak, Dorota Jesionek-Kupnicka, Cezary Chudobiński, Pawel Robak
Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Journal of clinical medicine 11 (23) (2022)
Tadeusz Robak, Jaroslaw D Kasprzak, Dorota Jesionek-Kupnicka, Cezary Chudobiński, Pawel Robak
Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Journal of clinical medicine 11 (23) (2022)
Tadeusz Robak, Jaroslaw D Kasprzak, Dorota Jesionek-Kupnicka, Cezary Chudobiński, Pawel Robak
Cardiac Involvement in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Journal of clinical medicine 11 (23) (2022)